ERBB2 and breast carcinoma: p95HER2, an oncogenic fragment of the tyrosine kinase receptor HER2, has been shown to induce senescence in a variety of breast cancer cell lines, whereas its associated secretome promotes metastasis in a non-cell autonomous manner.